HoLEP uses a holmium laser to enucleate enlarged prostate tissue from its capsule, providing a size-independent solution for benign prostatic hyperplasia. It is preferred in Spain over traditional methods like TURP due to reduced bleeding risks, shorter catheterization times, and exceptionally low long-term recurrence rates.
- Universal applicability: Effectively treats prostates over 80–100 mL without requiring invasive open surgery.
- Superior hemostasis: The laser seals vessels during surgery, minimizing bleeding for patients on anticoagulants.
- High durability: Long-term retreatment rates remain under 2% compared to 18% for traditional resection.
- Rapid recovery: Patients typically experience faster discharge and shorter hospital stays of 1–2 days.
Bookimed Expert Insight: While many clinics offer laser treatments, centers like Centro Médico Teknon in Barcelona stand out because they pioneered these methods in Spain 20+ years ago. Data suggests that choosing high-volume centers is vital since surgeon experience directly impacts the speed of urinary control recovery. Spain has become a top-4 global destination for this procedure partly because specialized directors like Dr. Javier Romero Otero integrate R&D with clinical practice.
Patient Consensus: Many patients choose HoLEP as a definitive, one-time fix for urinary blockages despite the risk of retrograde ejaculation. While initial irritation is common, the relief in flow is often described as immediate and life-changing.